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Bowel-associated dermatosis-arthritis syndrome
(BADAS) is a recurrent and episodic neutrophilic
dermatosis characterized by erythematous macules,
which quickly evolve into papules and vesiculopus-
tules on the trunk and upper extremities.1,2
Originally only associated with bariatric surgery,3
BADAS is now reported secondary to gastrointestinal
disease.4 Although typically seen in adults, we report
a case of a 4-year-old patient with numerous
scattered hemorrhagic vesicles and flu-like symp-
toms whose biopsy specimen revealed a neutro-
philic infiltrate consistent with BADAS. To our
knowledge, this is the youngest reported case of
BADAS in English-language literature.CASE REPORT
A 4-year-old African-American girl presented to
the emergency department after a several-day his-
tory of cough, congestion, intermittent fever, severe
intermittent abdominal pain, and bloody stools. She
had a medical history significant for sickle cell
disease, ulcerative colitis, and autoimmune hepatitis
being treated with hydroxyurea, mesalamine, and
azathioprine. On examination, she was noted to
have clusters of 2- to 7-mm hemorrhagic vesicles on
her palms, knees, and soles and a tender, swollen
right knee (Figs 1 to 3). Her laboratory workup
revealed an elevated C-reactive protein (31.1 mg/dL)
and white blood cell count (25.5 3 103/L), anemia
(hemoglobin 6.6 g/dL and hematocrit 18.7%), and
negative bacterial and viral cultures of vesicle fluid.the Department of Dermatology, Eastern Virginia Medical
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Her mother reported she had visited her pediatri-
cian and the emergency department for a similar
eruption diagnosed as Coxsackie virus and varicella
on 2 separate occasions. Four months prior, she was
admitted for a clinically identical episode that was
attributed to a sickle cell crisis versus a flare of
ulcerative colitis. At that time, dermatology was
consulted and a biopsy specimen of a pustule on
the patient’s left arm revealed a neutrophilic pan-
niculitis (Fig 4).
A repeated biopsy specimen obtained during her
most recent hospital admission showed subcorneal
and subepidermal edema and a prominent acute
inflammatory cell infiltrate composed entirely
of neutrophils. The inflammatory cell infiltrate
extended into the adipose tissue and into the septa.
A direct immunofluorescence study was also per-
formed, which was negative.
Because of recurrent episodes of fever (maximum
of 40.28C),malaise, abdominal pain, and arthritis with
the characteristic cutaneous lesions and histologic
findings in the setting of an ulcerative colitis flare, the
diagnosis of BADAS was made. The patient’s acute
flare was treated with an 11-day course of metroni-
dazole and prednisone. Infliximab infusions were
then started every 8 weeks in addition to her
azathioprine and mesalamine in an attempt to
control her colitis. Her skin lesions have not recurred
since her last admission. To our knowledge, this is the
youngest reported case of BADAS in English-
language literature.Correspondence to: Charlene W. Oldfield, MD, 721 Fairfax Ave. Suite
200, Norfolk, VA 23507. E-mail: Oldfield.Charlene@gmail.com.
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Fig 1. Bowel-associated dermatosis-arthritis syndrome.
Scattered hemorrhagic vesicles overlying a joint effusion.
Fig 2. Bowel-associated dermatosis-arthritis syndrome.
Scattered hemorrhagic vesicles.
Fig 3. Bowel-associated dermatosis-arthritis syndrome.
Scattered hemorrhagic vesicles.
Fig 4. Bowel-associated dermatosis-arthritis syndrome.
Neutrophilic panniculitis. (Hematoxylin-eosin stain; low-
power magnification.)
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BADAS is a recurrent and episodic neutrophilic
dermatosis characterized by erythematous macules,
which quickly evolve into papules and vesiculopus-
tules on the trunk and upper extremities. In most
cases after persisting for approximately 1 week, each
flare spontaneously resolves without scarring and
can be associated with relapses every 4 to 6 weeks.1,2
Eruptions of BADAS can be accompanied by non-
erosive tenosynovitis, polyarthralgias, diarrhea, and
flu-like symptoms such as myalgias and fever.2
Originally, the condition now known as BADAS
was referred to as bowel bypass syndrome because
of its association with bariatric surgery, in particular,
jejunoileal bypass.3 BADAS has been noted to occur
anywhere from a few postoperative days to up to
18 years postbariatric surgery. Although the inci-
dence of postoperative BADAS previously has ap-
proached 20%, newer surgical techniques have led to
a decline in these numbers.4,5 It was not until 1983
that 4 cases were published in which patients
presented with BADAS without a history of bariatric
surgery. These cases were instead associated with
gastrointestinal diseases within the adult population,
expanding the scope of the syndrome and giving
BADAS its current moniker.4 Since then BADAS hasbeen reported in cases of inflammatory bowel dis-
ease, diverticulitis, gastric phytobezoar, and even a
case of acute appendicitis.2 BADAS has also been
reported as the presenting prodrome of Crohn’s
disease in an adolescent, however to our knowledge,
this case illustrates one of the youngest pediatric
patients with this condition in the English-language
literature.6,7
The origin of BADAS is postulated to be the result
of bacterial overgrowth from either surgery, with the
creation of a blind loop in bariatric procedures, or
inflammation, as seen in intestinal diseases.2
Bacterial peptidoglycans accumulate during over-
growth resulting in an immune response and
antigen-complex deposition that is thought to elicit
the cutaneous findings in BADAS. This theory has
been tested in animal models using bacterial pepti-
doglycans of group A streptococci, which share
similar antigenicity and structure with human bacte-
rial intestinal flora, producing similar arthritis and
cutaneous findings to BADAS.8
Histologically BADAS is characterized by a
marked neutrophilic infiltrate and a lack of fibrinoid
necrosis.2 This appearance, however, is not
pathognomonic of BADAS. Histologically, Sweet
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be in the differential diagnosis, but clinical history
can often help distinguish the 2 syndromes. Other
diagnoses to consider could include pyoderma
gangrenosum, leukocytoclastic vasculitis, rheuma-
toid neutrophilic dermatosis, dermatitis herpetifor-
mis, and bacterial and viral infections such as
subacute endocarditis and gonococcal sepsis.1,3
In cases where BADAS does not remit spontane-
ously, treatment is directed toward the underlying
inflammatory disorder and bacterial overgrowth. As
such, steroids and antibiotics have been themainstay
treatment for BADAS; antibiotic choices can include
tetracycline, erythromycin, or metronidazole. In
addition, improved management and control of
any underlying intestinal disease can offer improve-
ment in BADAS.1-3 For BADAS associated with bar-
iatric procedures, surgical intervention may be
warranted to reduce the blind loops of bowel that
may lead to the bacterial overgrowth.2
In this case, the patient’s ulcerative colitis was
treated with infliximab infusions without recurrence
of BADAS. Given the sparse reports of BADAS in the
pediatric patient population it is not surprising that
the patient was initially given the diagnosis of a more
common entity such as varicella or Coxsackie virus.
However, this case illustrates that BADAS should beadded to the differential diagnosis of vesicles even in
very young patients with bowel disease.REFERENCES
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